DOCS vs PRVA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

DOCS

37.7
AI Score
VS
PRVA Wins

PRVA

49.9
AI Score

Investment Advisor Scores

DOCS

38score
Recommendation
SELL

PRVA

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DOCS PRVA Winner
Forward P/E 19.1571 23.6407 DOCS
PEG Ratio 0.5895 0 Tie
Revenue Growth 7.3% 21.4% PRVA
Earnings Growth -51.9% 250.0% PRVA
Tradestie Score 37.7/100 49.9/100 PRVA
Profit Margin 25.5% 1.2% DOCS
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD PRVA

Relative Price Performance (Last 90 Days)

DOCS 1M: +23.9% · 3M: +30.6% PRVA 1M: -15.4% · 3M: -6.7%

Current Technical Phase

DOCS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.3% over 20 days), RSI 58

RSI (14): 57.6 · Price: $25.33

PRVA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 28

RSI (14): 27.8 · Price: $21.12

Fundamentals Snapshot

Metric DOCS PRVA
Market Cap
Forward P/E 15.6 19.9
Trailing P/E 30.5 96.4
Revenue (TTM)
Revenue Growth 0.1% 0.2%
Gross Margin 0.9% 0.1%
Operating Margin 0.2% 0.0%
EPS 0.85 0.22
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PRVA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.